Luo YY - Search Results

1

Intestinal glucagon-like peptide-1: A new regulator of impaired counterregulatory responses to hypoglycemia in type 1 diabetes mellitus.

Liu LR, Luo YY, Su PZ, Zhang C, Li ZT. Liu LR, et al. Among authors: luo yy. World J Diabetes. 2025 Jan 15;16(1):99726. doi: 10.4239/wjd.v16.i1.99726. World J Diabetes. 2025. PMID: 39817207 Free PMC article.

2

YME1L-mediated mitophagy protects renal tubular cells against cellular senescence under diabetic conditions.

Luo Y, Zhang L, Su N, Liu L, Zhao T. Luo Y, et al. Biol Res. 2024 Mar 17;57(1):10. doi: 10.1186/s40659-024-00487-0. Biol Res. 2024. PMID: 38494498 Free PMC article.

3

Tumor Necrosis Factor Receptor-Associated Protein 1 Protects against Mitochondrial Injury by Preventing High Glucose-Induced mPTP Opening in Diabetes.

Liu L, Zhang L, Zhao J, Guo X, Luo Y, Hu W, Zhao T. Liu L, et al. Oxid Med Cell Longev. 2020 Mar 6;2020:6431517. doi: 10.1155/2020/6431517. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32215175 Free PMC article.

4

TRAP1 attenuates H9C2 myocardial cell injury induced by extracellular acidification via the inhibition of MPTP opening.

Zhang L, Liu L, Li X, Zhang X, Zhao J, Luo Y, Guo X, Zhao T. Zhang L, et al. Int J Mol Med. 2020 Aug;46(2):663-674. doi: 10.3892/ijmm.2020.4631. Epub 2020 Jun 4. Int J Mol Med. 2020. PMID: 32626957 Free PMC article.

5

ZBED3 exacerbates hyperglycemia by promoting hepatic gluconeogenesis through CREB signaling.

Luo YY, Ruan CS, Zhao FZ, Yang M, Cui W, Cheng X, Luo XH, Zhang XX, Zhang C. Luo YY, et al. Among authors: luo xh. Metabolism. 2025 Jan;162:156049. doi: 10.1016/j.metabol.2024.156049. Epub 2024 Oct 24. Metabolism. 2025. PMID: 39454821

6

Metabolomics in diabetic nephropathy: Unveiling novel biomarkers for diagnosis (Review).

Luo Y, Zhang W, Qin G. Luo Y, et al. Mol Med Rep. 2024 Sep;30(3):156. doi: 10.3892/mmr.2024.13280. Epub 2024 Jul 4. Mol Med Rep. 2024. PMID: 38963028 Free PMC article. Review.

7

Canagliflozin improves fatty acid oxidation and ferroptosis of renal tubular epithelial cells via FOXA1-CPT1A axis in diabetic kidney disease.

Gan T, Wang Q, Song Y, Shao M, Zhao Y, Guo F, Wei F, Fan X, Zhang W, Luo Y, Chen D, Wang S, Qin G. Gan T, et al. Mol Cell Endocrinol. 2024 Mar 1;582:112139. doi: 10.1016/j.mce.2023.112139. Epub 2023 Dec 19. Mol Cell Endocrinol. 2024. PMID: 38128823

8

Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns.

Shao M, Chen D, Wang Q, Guo F, Wei F, Zhang W, Gan T, Luo Y, Fan X, Du P, Liu Y, Ma X, Ren G, Song Y, Zhao Y, Qin G. Shao M, et al. Diabetologia. 2024 Apr;67(4):738-754. doi: 10.1007/s00125-023-06078-0. Epub 2024 Jan 18. Diabetologia. 2024. PMID: 38236410

9

Shenfu injection attenuates cardiac dysfunction and inhibits apoptosis in septic mice.

Zhao L, Jin L, Luo Y, Wang L, Li Y, Xian S, Zhao F. Zhao L, et al. Ann Transl Med. 2022 May;10(10):597. doi: 10.21037/atm-22-836. Ann Transl Med. 2022. PMID: 35722372 Free PMC article.

10

TRAP1 inhibits MIC60 ubiquitination to mitigate the injury of cardiomyocytes and protect mitochondria in extracellular acidosis.

Zhang L, Su N, Luo Y, Chen S, Zhao T. Zhang L, et al. Cell Death Discov. 2021 Dec 14;7(1):389. doi: 10.1038/s41420-021-00786-5. Cell Death Discov. 2021. PMID: 34907169 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters